-
PathoAI Secures Tens of Millions in Angel Financing for AI-Powered Pathology Solutions
•
PathoAI, a company at the forefront of intelligent pathology and examination through artificial intelligence (AI), has reportedly raised tens of millions of renminbi in an angel financing round. The funding was led by Hangzhou Taikun Equity Investment Fund Partnership, with participation from Deshi Capital. PathoAI’s Focus on AI Products and…
-
HuidaGene Secures US Patent for High-Efficiency Cas12Max DNA Editing System
•
HuidaGene Therapeutics, a China-based biotechnology company, has announced the receipt of patent protection from the US Patent and Trademark Office (USPTO) for its cutting-edge DNA editing system, Cas12Max (CRISPR-Cas12i). This system is recognized for its superior DNA editing efficiency in mammalian cells compared to other competing systems, such as Streptococcus…
-
XtalPi Inc. and China Pharmaceutical University Launch Joint AI Research Center in China
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has joined forces with China Pharmaceutical University (CPU) to establish a joint research center in China. This collaboration aims to leverage the strengths of both institutions in the field of AI and pharmaceutical research. Innovative Laboratory Automation and Intelligent SystemsThe project features an…
-
Omega Medical Imaging’s Soteria.AI Receives FDA Approval for Interventional Cardiology
•
US-based medical technology firm Omega Medical Imaging has received marketing approval from the US Food and Drug Administration (FDA) for its Soteria.AI, an image-guided X-ray system specifically designed for interventional cardiology labs. This marks a significant milestone as Soteria.AI is hailed as the first artificial intelligence (AI)-enabled X-ray system approved…
-
Ping An Healthcare and Technology Partners with Chugai Pharmaceutical to Establish Angina Pectoris Center
•
Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also recognized as PingAn Good Doctor, has entered into a partnership with Japanese firm Chugai Pharmaceutical to jointly establish an angina pectoris center. This collaboration aims to integrate medical expertise with technological innovation to enhance coronary heart disease management. Advancing Coronary…
-
Smith & Nephew Partners with MedMotion for Digital Health Innovation
•
UK-based Smith & Nephew Plc has announced a strategic partnership with China’s Shanghai Fudong Medical Management Co., Ltd, also known as MedMotion, a leading digital health company. This collaboration aims to enhance digitalization innovation and explore comprehensive “pre-operative, intraoperative, and post-operative” perioperative management solutions. Aim to Revolutionize Post-Operative RehabilitationThe partnership…
-
Vas Healthcare Raises RMB 100 Million in Angel Financing for Robot Development
•
Vas Healthcare, a developer of vascular interventional surgery robots based in Beijing, has reportedly raised RMB 100 million (USD 14.5 million) in an angel financing round. The round was co-led by CAS Investment and Noah Capital. The funds will be used to support technology research and development, new product iteration,…
-
XtalPi and DP Technology Partner to Accelerate Pre-Clinical Drug Development with AI
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has entered into a partnership with Beijing-based DP Technology. The collaboration aims to leverage DP Tech’s AI for Science computation platform and XtalPi’s intelligent, automatic drug research and development (R&D) solutions to streamline the pre-clinical drug R&D process, thereby accelerating drug development. XtalPi’s…
-
XtalPi and Chia Tai Tianqing Achieve Phase II Milestone in Cancer Drug Development
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has partnered with China’s Chia Tai Tianqing to reach the Phase II milestone in their small molecule cancer drug research and development (R&D) program. The collaboration leveraged Chia Tai Tianqing’s in-house innovative drug innovation platform and XtalPi’s AI drug discovery platform to achieve…
-
TandemAI Secures $35M Series A to Expand Drug Discovery Platform
•
TandemAI, a technology firm with operations in New York, San Diego, and China, has successfully completed a USD 35 million Series A finance round. The funds raised will be utilized to expand the company’s drug discovery service platform, enhancing its capabilities in the biotech sector. This strategic financing round attracted…
-
Glowe Raises Series A+ Funding to Expand AIGC in Mental Health
•
Glowe, an online psychological consultation platform based in Guangdong, has reportedly raised “tens of millions” of renminbi in a Series A+ financing round. The round was led by FreesFund, with proceeds intended to ramp up the application of Artificial Intelligence Generated Content (AIGC) in the platform’s services. Glowe: Platform Overview…
-
Kactus Biosystems and Levinthal Biotech Deepen Strategic Partnership
•
Kactus Biosystems, a Shanghai-based firm specializing in target proteins and raw enzymes, has announced a deepened strategic partnership with Levinthal Biotech, an AI-empowered protein design company headquartered in Hangzhou. The collaboration aims to advance research and development in next-generation gene therapy and mRNA vaccine fields, marking a significant step forward…
-
MoleculeMind Raises Over RMB 100 Million for AI Protein Design Platform
•
MoleculeMind, an artificial intelligence (AI)-empowered protein design platform based in Beijing, has reportedly raised over RMB 100 million (USD 14.58 million) in its latest financing round. The round was led by Cathay Biotech Inc. (SHA: 688065), a synthetic biology firm based in Shanghai, with contributions from Lenovo Capital and Sequoia…
-
WinHealth Pharma Taps Baidu’s ERNIE Bot for Rare Disease Services
•
China-based Hong Kong WinHealth Pharma Group Ltd’s Bo’Ao Winhealth Rare Disease Medical Center has accessed Baidu’s ERNIE Bot, the China-based internet giant’s answer to the current global phenomenon ChatGPT. This strategic move will enhance the company’s capabilities in the rare disease sector by leveraging Baidu’s leading intelligent conversation technology. Application…
-
Asieris Partners with ReviR Therapeutics for Urogenital Cancer Research
•
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has struck a partnership with compatriot firm ReviR Therapeutics, an artificial-intelligence (AI) and gene tech-powered start-up. The collaboration aims to utilize ReviR’s in-house developed AI drug research and development (R&D) platform and targeted RNA technology to conduct research…
-
Insilico Medicine Opens AI Biotech Research Center in Abu Dhabi
•
China-based AI-powered drug discovery firm Insilico Medicine has revealed the opening of an AI-powered biotechnology research center in Abu Dhabi. This new facility, the Insilico Medicine Generative Artificial Intelligence and Quantum Computing Research and Development Centre, will offer the firm’s end-to-end AI-driven drug discovery platform, Pharma.AI, and explore aging research…
-
MindRank AI Receives FDA Approval for MDR-001 Clinical Study in Obesity
•
Hangzhou-based artificial intelligence (AI)-driven biotech MindRank AI has announced obtaining approval from the US FDA to conduct a clinical study for its oral, small molecule GLP-1 receptor agonist (RA) drug MDR-001 in obesity. This marks a significant milestone in the development of MDR-001, positioning MindRank AI to advance its innovative…
-
XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with the Experimental Drug Development Centre (EDDC) of Singapore. The aim is to provide new drug candidates for lung cancer precision treatment, driven by a research and development model integrating artificial intelligence (AI), automation experimentation, and expert expertise. No…
-
ClinBrain and WCH Establish Joint Laboratory for Geriatric Information Platform
•
Shanghai-based ClinBrain, a clinical data repository (CDR) and medical big data services provider, together with the National Clinical Research Center for Geriatric Diseases (WCH), announced the establishment of a “joint laboratory of geriatric information platform.” The two will work together on clinical research applications, the construction of a high-quality clinical…
-
Roche and Zhongshan Hospital Collaborate on Clinical Studies and Innovation Center
•
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a cooperation memorandum of understanding (MoU) with Shanghai’s Class 3A Zhongshan Hospital, a major teaching hospital affiliated to China’s National Health Commission. The three entities will collaborate on clinical studies in cancer and other diseases, create…
